Library / Laws / 114th Congress / House Bills / H.R. 2338
H.R. 2338
To amend the Federal Food, Drug, and Cosmetic Act to provide for the development and use of patient experience data to enhance the structured risk-benefit assessment framework, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2015-05-14 | 5.7K | ⠃⠗⠋ |